Second Meningitis Vaccine Doses Offered After U.K. Outbreak

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 13, 2026.

via HealthDay

MONDAY, April 13, 2026 — Nearly 12,000 people in the U.K. who received a first dose of the MenB vaccine will now be offered a second shot starting next week, after a deadly meningitis outbreak linked to a university in Kent.

The outbreak led to two deaths and 19 confirmed cases in a short period, according to NHS Kent.

A 21-year-old university student and a younger secondary-school student both died after getting the infection, BBC reported.

Health officials described the situation as "unprecedented" because so many people got sick so quickly.

The vaccination campaign has focused on people who may have been exposed, including:

  • Students living in dorms
  • People who visited a nightclub linked to the outbreak
  • Some additional school and college students

    • Clinics will open in Canterbury, Faversham and Ashford, and eligible people can book appointments online, BBC reported.

    The MenB vaccine requires two doses for full protection.

    The second shot is given at least four weeks after the first, though it can be given later.

    The vaccine protects against most types of meningococcal group B bacteria in the U.K., BBC said.

    The outbreak prompted a national response, with the U.K. Health Security Agency stepping in to support efforts like giving out antibiotics.

    Officials are also reviewing whether more teenagers should be offered the MenB vaccine in the future.

    Sources

  • BBC, April 12, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-14 02:09

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords